THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE A PROSPECTUS OR OFFERING MEMORANDUM OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES OF TUNGSTEN WEST PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT IN RESPECT OF TUNGSTEN WEST PLC AND SHOULD NOT BE CONSIDERED AS A RECOMMENDATION THAT ANY INVESTOR SHOULD SUBSCRIBE FOR OR PURCHASE ANY SUCH SECURITIES.

​

This Announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended by the European Union (Withdrawal) Act 2020 ("UK MAR").  In addition, market soundings (as defined in UK MAR) were taken in respect of certain of the matters contained in this Announcement, with the result that certain persons became aware of such inside information, as permitted by UK MAR.  Upon the publication of this Announcement, this inside information is now considered to be in the public domain and such persons shall therefore cease to be in possession of inside information.

Capitalised terms not otherwise defined in the text of this Announcement have the meanings given in the Company's accelerated bookbuild launch announcement released at 7.00 a.m. on 5 February 2026, unless otherwise specified.

6 February 2026

Tungsten West Plc

 ("Tungsten West" or the "Company")

Result of Bookbuild and Subscription Raising c.£41.37 million

Tungsten West (AIM: TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon in the UK, announces the results of the Bookbuild which together with the Subscription and other direct subscriptions has raised gross proceeds of £41,369,718. 

The Company has placed 59,746,113 Ordinary Shares with new institutional investors and existing shareholders pursuant to the Placing at a price of £0.18 per share (the "Issue Price"), raising gross proceeds of £10,754,300, a further 162,712,757 new Ordinary Shares pursuant to the Company's direct Subscription with a prominent international investor ("Subscriber"), raising gross proceeds of £29,288,296. The Issue Price represents a premium of approximately 9.9 per cent. to the 30-day VWAP of 16.38 pence per Existing Ordinary Share up to and including 4 February 2026 and a discount of approximately 39.0 per cent. to the closing middle market price of 29.50 pence per Ordinary Share on 4 February 2026.

Hannam & Partners acted as Bookrunner and Placing Agent in connection with the Placing.

In total, the Subscription and Placing was more than 2.5 times oversubscribed, receiving strong support from existing and new investors, allowing the Company to broaden its institutional following and market support.  The Company increased the size of fundraise by £1.1 million to cater for direct subscriptions for new Ordinary Shares with the Company, conditional upon the passing of the Resolutions at the General Meeting and Second Admission. The Placing Shares and the Subscription Shares represent, in aggregate, approximately 17.6 per cent. of the Company's issued share capital (including B Shares) prior to the Fundraise and prior to the closing of the Retail Offer. 

As part of the Company's fundraise, Stephen Harrison, David Cather, Kevin Ross and Philip Povey subscribed for new Ordinary Shares directly with the Company and Richard Maxey,  Jeffery Court, and Guy Edwards subscribed for Retail Offer Shares pursuant to the Retail Offer (the "Participating Directors") acquiring in aggregate, 1,952,898 new Ordinary Shares at the Issue Price (the "Director Participation Shares"), raising £351,522 for the Company (before expenses) (the "Directors' Participation") conditional upon the passing of the Resolutions at the General Meeting and Second Admission.

Details of the Directors' Participation in the Company's fundraise are set out as follows:

* Philip Povey holds his interest in 2,995,305 Ordinary Shares through Umbrella Mountain Limited, a company in which he is the sole shareholder and director.  Philip Povey does not have any beneficial interest in any other shares held by Umbrella Mountain Limited.  

Related Party Transactions

Lansdowne on its own behalf or its related funds or nominees participated in the Placing acquiring 40,678,189 new Ordinary Shares for an aggregate amount of £7.32 million / US$10 million (the "Lansdowne Participation").  Lansdowne currently holds 29.90 per cent. of the Company's issued share capital, and assuming no B Shares are converted will hold approximately 26.67 per cent. of the Company's issued share capital on Second Admission (subject to the passing of the Resolutions at the General Meeting to be held on 26 February 2026).  Lansdowne is therefore considered to be a related party as a substantial shareholder as such terms are defined under the AIM Rules. In addition, the issue of Director Participation Shares to the Directors, also constitutes a related party transaction pursuant to Rule 13 of the AIM Rules, by virtue of their status as Directors of the Company.  Accordingly, the independent director for the purposes of the related party transactions, Martin Wood, having consulted with the Company's nominated adviser, Strand Hanson, considers the terms of Lansdowne's Participation and the Directors' Participation in the Placing to be fair and reasonable in accordance with AIM Rule 13 following such commitments being made insofar as the Shareholders are concerned.

Jeffery Court, CEO of Tungsten West, commented:

"We are extremely pleased that the market has shown such strong support for the Company.  These funds are a cornerstone for the re-start of operations at Hemerdon in a time of very buoyant commodity prices.  We welcome new shareholders and the increased investment from our pre-existing shareholders, who both strongly believe in the vision we have for the Company."

"Our focus now is to accelerate our re-commissioning programme and get into production as quickly as possible, whilst concluding the advanced positions we have on the Project debt package."

"I extend my personal gratitude to all of our employees, consultants and advisers for their extremely hard work that has led to this achievement, in addition to thanking our pre-existing and new shareholders for their support."

Admission of Shares

Application will be made for 40,253,887 Ordinary Shares, which have been allocated as First Tranche Subscription Shares and 59,746,113 Ordinary Shares which have been allocated as First Tranche Placing Shares to be admitted to trading on AIM on First Admission.  It is anticipated that First Admission will become effective, and that dealings in the Ordinary Shares will commence, at 8.00 a.m. (London time) on 11 February 2026.  The 129,831,768 Ordinary Shares allocated as Second Tranche Subscription Shares and which have been allocated as Second Tranche Placing Shares will be issued on Second Admission, anticipated to be 8.00 a.m. on 27 February 2026 subject to the Resolutions being approved by Shareholders at the General Meeting.  

In addition to the Placing and Subscription, the Company also announced that it is providing Retail Investors with the opportunity to subscribe for Retail Offer Shares at the Issue Price via the RetailBook platform.  The results of the Retail Offer will also be announced separately thereafter.  Retail Offer Shares purchased pursuant to the Retail Offer will be admitted on Second Admission (subject to the Resolutions being passed at the General Meeting). 

Notice of the General Meeting will be sent to Shareholders on 9 February 2026.

Total Voting Rights on First Admission

Following First Admission and prior to Second Admission, the total number of shares in issue in the Company will be 875,220,231 Ordinary shares of £0.01 each and 490,402,989 B shares of £0.01 each. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Ordinary Shares, when issued, will be fully paid and will rank pari passu in all respects with each other and with the existing Ordinary Shares of the Company, including, without limitation, the right to receive all dividends and other distributions declared, made or paid after the date of issue.

For additional information please contact:

THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

This Announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Australia, Canada, Japan, the Republic of South Africa, Hong Kong or any other jurisdiction in which the same would be unlawful or to any person to whom it is unlawful to make such offer or solicitation. No public offering of the Placing Shares is being made in any such jurisdiction.

No action has been taken by the Company or Hannam & Partners or any of their respective Affiliates or any of its or their respective directors, officers, partners, employees, agents or advisers (collectively "Representatives") or any person acting on behalf of any of them that would, or is intended to, permit an offer of the Placing Shares or result in the possession or distribution of this Announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdiction. Persons into whose possession this Announcement comes are required to inform themselves about, and to observe, such restrictions.

No prospectus, offering memorandum, offering document or admission document has been or will be made available in any jurisdiction in connection with the matters contained or referred to in this Announcement and no such document is required (in accordance with Regulation (EU) No 2017/1129 (the "EU Prospectus Regulation") or the Public Offers and Admissions to Trading Regulations 2024 (the "POATR")) to be published. Persons needing advice should consult a qualified independent legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

All offers of the Placing Shares will be made pursuant to an exemption under the POATR or the EU Prospectus Regulation from the requirement to produce an admission document or prospectus. This Announcement is being distributed and communicated to persons in the UK only in circumstances to which section 21(1) of the Financial Services and Markets Act, 2000, as amended, does not apply.

THE PLACING SHARES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION OF THE UNITED STATES, AND MAY NOT BE OFFERED, SOLD, PLEDGED, TAKEN UP, EXERCISED, RESOLD, TRANSFERRED OR DELIVERED, DIRECTLY OR INDIRECTLY, WITHIN, IN OR INTO THE UNITED STATES ABSENT REGISTRATION UNDER THE SECURITIES ACT OR AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. THERE WILL BE NO PUBLIC OFFERING OR THE SECURITIES IN THE UNITED STATES. NO PUBLIC OFFERING OF THE SHARES REFERRED TO IN THIS ANNOUNCEMENT IS BEING MADE IN THE UNITED KINGDOM, HONG KONG, CANADA, ANY OTHER RESTRICTED JURISDICTION (AS DEFINED BELOW) OR ELSEWHERE.

THE PLACING HAS BEEN CONDUCTED OUTSIDE THE UNITED STATES IN AN "OFFSHORE TRANSACTION" IN RELIANCE ON REGULATION S UNDER THE SECURITIES ACT AND, SEPARATELY, ANY OFFER AND SALE OF SECURITIES IN THE UNITED STATES, IF MADE, WILL BE MADE ONLY IN TRANSACTIONS NOT INVOLVING ANY PUBLIC OFFERING PURSUANT TO SECTION 4(A)(2) OF THE SECURITIES ACT AND ONLY TO PERSONS THAT INITIATE THE TRANSACTION ON AN UNSOLICITED BASIS. NEITHER THE U.S. SECURITIES AND EXCHANGE COMMISSION NOR ANY U.S. STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS ANNOUNCEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE IN THE UNITED STATES. 

THE COMPANY WILL HAVE NO OBLIGATION TO, AND DOES NOT INTEND TO, REGISTER ANY RESALE OF THE PLACING SHARES IN THE UNITED STATES.

The Bookrunner is not registered as a broker-dealer in the United States and will not solicit or induce the purchase or sale of any security in the United States. Any order from a U.S. person will be accepted only if initiated by such person on an unsolicited basis, and any direct communications with the Company or the Bookrunner in connection with such purchase have been initiated by the purchaser and have not involved any solicitation.

If you are in any doubt about any of the contents of this Announcement, you should obtain independent professional advice.

This Announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside the United Kingdom.

This Announcement has not been approved by the Financial Conduct Authority (the "FCA") or the London Stock Exchange.